Growth Metrics

OmniAb (OABI) Accumulated Depreciation & Amortization (2021 - 2026)

OmniAb (OABI) reported Accumulated Depreciation & Amortization of $19.9 million for Q1 2026, up 320.37% year-over-year from $4.7 million in Q1 2025, and down 8.35% on a QoQ basis from $21.8 million in Q4 2025.

OmniAb (OABI) has 6 years of Accumulated Depreciation & Amortization data on file, last reported at $19.9 million in Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 320.37% year-over-year to $19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (up 320.37% YoY) and the FY2025 annual result came in at $21.8 million, down 7.76% from the prior year.
  • Accumulated Depreciation & Amortization fell to $19.9 million in Q1 2026 per OABI's latest filing, from $21.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $23.6 million in Q4 2024 and bottomed at $4.4 million in Q1 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $13.4 million (2022), against an average of $12.9 million.
  • The widest annual swing landed in 2025, when Accumulated Depreciation & Amortization retreated 15.0%; it then surged 320.37% in 2026.
  • Tracing OABI's Accumulated Depreciation & Amortization over 5 years: stood at $18.2 million in 2022, then climbed by 6.84% to $19.5 million in 2023, then advanced by 20.96% to $23.6 million in 2024, then slipped by 7.76% to $21.8 million in 2025, then dropped by 8.35% to $19.9 million in 2026.
  • Per Business Quant, the three latest OABI Accumulated Depreciation & Amortization figures stand at $19.9 million (Q1 2026), $21.8 million (Q4 2025), and $14.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.94 Mn
Mar 31, 2026 19.94 Mn
Dec 31, 2025 21.75 Mn
Dec 31, 2025 21.75 Mn
Sep 30, 2025 14.05 Mn
Sep 30, 2025 14.05 Mn
Jun 30, 2025 9.39 Mn
Jun 30, 2025 9.39 Mn
Mar 31, 2025 4.74 Mn
Mar 31, 2025 4.74 Mn
Dec 31, 2024 23.58 Mn
Dec 31, 2024 23.58 Mn
Sep 30, 2024 15.98 Mn
Sep 30, 2024 15.98 Mn
Jun 30, 2024 11.05 Mn
Jun 30, 2024 11.05 Mn
Mar 31, 2024 4.95 Mn
Mar 31, 2024 4.95 Mn
Dec 31, 2023 19.50 Mn
Dec 31, 2023 19.50 Mn
Sep 30, 2023 14.56 Mn
Sep 30, 2023 14.56 Mn
Jun 30, 2023 9.72 Mn
Jun 30, 2023 9.72 Mn
Mar 31, 2023 4.86 Mn
Mar 31, 2023 4.86 Mn
Dec 31, 2022 18.25 Mn
Dec 31, 2022 18.25 Mn
Sep 30, 2022 13.43 Mn
Sep 30, 2022 13.43 Mn
Jun 30, 2022 8.93 Mn
Jun 30, 2022 8.93 Mn
Mar 31, 2022 4.44 Mn
Mar 31, 2022 4.44 Mn
Dec 31, 2021 16.25 Mn
Dec 31, 2021 16.25 Mn